Targeted release via thermal sensitivity

Targeted release via thermal sensitivity is not an actual molecular therapeutic target such as a receptor, enzyme, transporter, or similar biomolecule. Instead, it refers to a **drug delivery strategy** that exploits materials (such as phase-change materials, thermosensitive liposomes, or thermoresponsive polymers) designed to release their payload at elevated temperatures above physiological norms, typically in the range of 39–44 °C[1][2][4][5]. This approach allows for localized or on-demand drug release by externally raising the temperature (for example, via focused heating or hyperthermia at tumor sites) or taking advantage of temperature rises due to pathological conditions. The molecular trigger for release is a physical change (such as melting or increased membrane permeability) in the carrier material, not a specific biological target. Therefore, 'targeted release via thermal sensitivity' is a **description of a delivery mechanism**, not a defined molecular target.

Other names

Temperature-sensitive drug releaseThermal-triggered releaseThermosensitive drug deliveryTriggered release via thermal sensitivityTemperature-sensitive release

Release of encapsulated drugs mediated by physical (thermal) triggering; Phase transition of carrier material at a set temperature releases drug payload